Progression Free Survival at 12 Months After First-Line Therapy Is Associated With Favourable Outcomes After First Relapse/Progression in Peripheral T-Cell Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.148_2631

Related search